|
SARS相关的论著
SARS
Reference(SARSReference－7.10)
流行病学
SARS:Capture-recapture
method should be used to count how many cases of SARS really exist
(BMJ－6.21)
SARS:Lessons
may be learnt from the outbreak of legionnaires' disease in Barrow
in Furness (BMJ－6.21)
Transmission
Dynamics and Control of Severe Acute Respiratory Syndrome (Science－6.20)
Transmission
Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of
Public Health Interventions (Science－6.20)
Control
Measures for Severe Acute Respiratory Syndrome in Taiwan(Emerging
Infectious Diseases－6.3)
Severe
Acute Respiratory Syndrome (SARS)in Singapore- Clinical Features
of Index Patient and Initial Contacts (Emerging Infectious
Diseases－6.3)
Modeling
the SARS Epidemic(Science－5.23)
Transmission
Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of
Public Health Interventions(Science－5.23)
Transmission
Dynamics and Control of Severe Acute Respiratory Syndrome(Science－5.23)
Preventing
local transmission of SARS : lessons from Singapore(MJA－5.19)
A
multicentre collaboration to investigate the cause of severe acute
respiratory syndrome(Lancet－5.16)
Epidemiological
determinants of spread of causal agent of severe acute respiratory
syndrome in Hong Kong(Lancet－5.7)
Clinical
Features and Short-term Outcomes of 144 Patients With SARS in the
Greater Toronto Area(JAMA－5.7)
First data
on stability and resistance of SARS coronavirus compiled by members
of WHO laboratory network(WHO－5.4)
Prospective
study of the clinical progression and viral load of SARS associated
coronavirus pneumonia in a community outbreak(WHO－5.4)
Case Definitions
for Surveillance of SARS(WHO－5.3)
Modelers
Struggle to Grasp Epidemic's Potential Scope(Science－4.25)
The SARS epidemic:
lessons for Australia(MJA－4.21)
SARS
update(CMAJ－4.17)
Epidemiology,
Clinical Presentation And Laboratory Investigationof Severe Acute
Respiratory Syndrome (Sars)In Canada,March 2003(Can
Commun Dis Rep－4.15)
A Major
Outbreak of Severe Acute Respiratory Syndrome in Hong Kong(NEJM－4.07)
Identification
of Severe Acute Respiratory Syndrome in Canada(NEJM－3.31)
A Cluster of Cases
of Severe Acute Respiratory Syndrome in Hong Kong(NEJM－3.31)
Top
SARS病毒
A
new infectious disease challenge: Urbani severe acute respiratory
syndrome (SARS)associated coronavirus (Immunology－6.16)
SARS病原学的确立(北大医学部微生物学系－彭宜红、朱永红)
(CMBI－6.1)
Severe
Acute Respiratory Syndrome (SARS)and Coronavirus Testing—United States(JAMA－5.7)
Coronaviruses
- the cause of SARS(Principles of Molecular Virology－4.27)
WHO biosafety
guidelines for handling of SARS specimens(WHO－4.26)
电镜观察从非典型肺炎患者尸检标本中发现衣原体样和冠状病毒样颗粒(中华医学杂志－4.25)
Severe acute respiratory
syndrome (SARS)and coronavirus testing--United States, 2003(CDC-MMWR－4.24)
Calling All Coronavirologists(Science－4.18)
Coronavirus
never before seen in humans is the cause of SARS(WHO－4.16)
Identification of
a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome(NEJM－4.10)
A Novel Coronavirus
Associated with Severe Acute Respiratory Syndrome(NEJM－4.10)
Coronavirus as
a possible cause of severe acute respiratory syndrome(LANCET－4.8)
Novel
coronavirus and severe acute respiratory syndrome(LANCET－4.08)
Top
ARS病毒基因组
SARS综述:SARS病毒基因组与侵入宿主细胞研究近况－幻灯片(CMBI－版本
5.14)update
序列分析
mRNA Cap-1
Methyltransferase in the SARS Genome(Cell－6.13)
The
Genome Sequence of the SARS-Associated Coronavirus(Science－5.30)
Mass Spectrometric
Characterization of Proteins from the SARS Virus: a Preliminary Report(Mol
Cell Proteomics－5.29)
The
Genome Sequence of the SARS-Associated Coronavirus (Science－5.2)
Characterization
of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome(Science－5.2)
A complete sequence
and comparative analysis of strain (BJ01)of the SARS-associated virus(Chinese
Science Bulletin－5.3)
Comparative full-length
genome sequence analysis of 14 SARS coronavirus isolates and common
mutations associated with putative origins of infection(Lancet－5.9)
The preliminary Analysis
of SARS associated Coronavirus Genome and Mutation Distribution(CMBI－5.1)
The Preliminary analysis
of the structure and function of the putative proteins of SARS coronavirus(CMBI－5.1)
The Preliminary
Analysis of SARS Coronavirus Proteins' Sequences－Where does the virus'
RNA polymerase come from?
(CMBI－5.1)
Preliminary analysis
of the structure and function of SARS putative nucleocapsid protein(CMBI－5.4)
Tertiary Structure
Prediction of SARS Coronavirus Proteins' Partial Sequence(CMBI－5.9)
SARS冠状病毒预测蛋白的种系进化分析(北京大学人类疾病基因研究中心－5.1)
SARS病毒的背景和初步分析(BioSino－4.29)
重症急性呼吸综合征病例尸解肺组织中新型冠状病毒部分聚合酶基因的序列测定(军事医学科学院院刊－4.25)
PCR primers for
SARS developed by WHO Network Laboratories (WHO－4.15)
Nucleotide
Sequence of Human Coronavirus, CoV-SARS(US CDC－4.13
Coronavirus
Protein Analysis Phylogenetic Trees(USCDC－4.13)
SARS
Co-V-Host Cell Interaction
A
3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual
screening(Acta Pharmacol Sin－6.10)
Small
envelope protein E of SARS: cloning, expression, purification, CD
determination, and bioinformatics analysis1(Acta
Pharmacol Sin－6.10)
SARS_Cov刺突蛋白入侵宿主细胞的机制假说模型(温州师范学院生命与环境科学学院－陈银道)(CMBI－6.3)
Coronavirus
Main Proteinase (3CLpro)Structure: Basis for Design of
Anti-SARS Drugs(Science－5.13)
Nuclear
targeting sequence in SARS nucleocapsid protein (CMBI－5.9)
Searching
the possible binding site of the SARS N protein and SARS RNA(CMBI－5.9)
The
Potential Proteins Which induce SARS Virus enter host(CMBI－5.9)
SARS
coronavirus proteins may contain caveolin binding sites(北京大学人类疾病基因研究中心－5.7)
The Preliminary Analysis
of SARS Proteins' Sequences (I)(CMBI－4.29)
其他
Virus-encoded
proteinases and proteolytic processing in the Nidovirales(Journal
of General Virology－5.2)
Influenza-virus-induced
signaling cascades: targets for antiviral therapy?(TRENDS in
Molecular Medicine－4.24)
Top
临床相关
SARS综述:传染性非典型肺炎的临床和治疗进展－幻灯片(CMBI－版本
5.21)update
SARS:Guidelines
were drawn up collaboratively to protect healthcare workers in British
Columbia(BMJ－6.21)
SARS:
Private hospital in Singapore took effective control measures (BMJ－6.21)
SARS:Clinical
outcome after inpatient outbreak of SARS in Singapore (BMJ－6.21)
Evaluation
of WHO criteria for identifying patients with severe acute respiratory
syndrome out of hospital: prospective observational study(BMJ－6.21)
Haematological
manifestations in patients with severe acute respiratory syndrome:
retrospective analysis(BMJ－6.21)
Glycyrrhizin,
an active component of liquorice roots, and replication of SARS-associated
coronavirus(Lancet－6.14)
Updated
SARS case definition using laboratory criteria(JAMC－6.10)
Hiding
in the Bunker: Challenges for a radiation oncology department operating
in the Severe Acute Respiratory Syndrome outbreak(Australas
Radiol－6.3)
SARS
coronavirus: a new challenge for prevention and therapy(J
Clin Invest－6.1)
WHO
is SARS?(Lancet Infectious Diseases－6.1)
SARS
sequencing paves the way for better diagnostics(Lancet Infectious
Diseases－6.1)
Severe
acute respiratory syndrome in developing countries(Lancet
Infectious Diseases－6.1)
Our
Strategies for Fighting Severe Acute Respiratory Syndrome (SARS)(Am
J Respir Crit Care Med－5.28)
Clinical
course and management of SARS in health care workers in Toronto: a
case series(CMAJ－5.28)
Anaesthesia
and SARS(Br J Anaesth－5.26)
Severe
Acute Respiratory Syndrome: Radiographic Appearances and Pattern of
Progression in 138 Patients(Radiology－5.20)
Lung
pathology of fatal severe acute respiratory syndrome(Lancet－5.16)
Atypical
presentations of SARS(Lancet－5.16)
The
Use of Corticosteroids in SARS(NEJM－5.15)
Radiologic
Manifestations of Severe Acute Respiratory Syndrome(NEJM－5.15)
Development
of a standard treatment protocol for severe acute respiratory syndrome(Lancet－5.10)
Clinical
progression and viral load in a community outbreak of coronavirus-associated
SARS pneumonia - a prospective study(Lancet－5.9)
Thin-Section
CT of Severe Acute Respiratory Syndrome: Evaluation of 73 Patients
Exposed to or with the Disease
(Radiology－5.8)
WHO collaborative
multi-centre research project on Severe Acute Respiratory Syndrome
(SARS)diagnosis(WHO－5.4)
Aminopeptidase
N inhibitors and SARS(Lancet－5.4)
Effectiveness of
precautions against droplets and contact in prevention of nosocomial
transmission of severe acute respiratory syndrome (SARS)(Lancet－5.4)
Haemorrhagic-fever-like
changes and normal chest radiograph in a doctor with SARS(Lancet－5.4)
Use of
laboratory methods for SARS diagnosis(WHO－5.3)
Sampling for
SARS diagnostic tests(WHO－5.3)
SARS
Laboratory diagnostic tests(WHO－5.3)
SARS冠状病毒多聚酶基因临床检测方法的建立(第一军医大学学报－5)
反转录巢式PCR方法检测SARS冠状病毒(第一军医大学学报－5)
SARS临床诊治现状
－ 钟南山(中国医学论坛报－4.29)
Clinical
presentations and outcome of severe acute respiratory syndrome in
children(Lancent－4.29)
Genetic
Variability: The Key Problem in the Prevention and Therapy of RNA-Based
Virus Infections(Medicinal Research Reviews－4.29)
Identification
and containment of an outbreak of SARS in a community hospital(CMAJ－4.25)
Rhinovirus and
Coronavirus Infection-Associated Hospitalizations among Older Adults(J.
of Infectious Diseases－4.24)
Ribavirin in the
treatment of SARS: A new trick for an old drug?(CMAJ－4.24)
The
immediate psychological and occupational impact of the 2003 SARS outbreak
in a teaching hospital(CMAJ－4.24)
The plague
within: an Australian doctor’s experience of SARS in Hong Kong(MJA－4.21)
Outbreak
of severe acute respiratory syndrome in Hong Kong Special Administrative
Region: case report(BMJ－4.19)
Treatment
of severe acute respiratory syndrome with convalescent plasma(Hong
Kong Med J－4.17)
Severe
acute respiratory syndrome in a doctor working at the Prince of Wales
Hospital(Hong Kong Med J－4.17)
Advancing
HIV Prevention and Severe Acute Respiratory Syndrome(SARS)(CDC－4.17)
Preliminary
Clinical Description of Severe Acute Respiratory Syndrome(Can
Commun Dis Rep－4.15)
Guideline
on management of severe acute respiratory syndrome(LANCET－4.08)
Top
护理
Heroes,
SARS, staffing, and family presence(J
Emerg Nurs－6.1)
Challenging
beliefs and ethical concepts: the collateral damage of SARS(Critical
Care－5.29)
ICU
management of severe acute respiratory syndrome(Intensive
Care Med－5.9)
Severe
Acute Respiratory Syndrome - Providing Care in the Face of Uncertainty(JAMA－5.7)
Improving
the care for patients with acute severe respiratory disease(THORAX－4.24)
Top
评论与综述
SARS: Threat
of tuberculosis persists(BMJ－6.21)
SARS:Numbers
do not tell whole story (BMJ－6.21)
SARS
genome patent: symptom or disease?(Lancet－6.14)
Web
serves as conduit for SARS information(Lancet
Infectious Diseases－6.3)
Severe
acute respiratory syndrome in developing countries(Lancet
Infectious Diseases－6.3)
The
SARS Coronavirus:A Postgenomic Era (Science－5.30)
A new vision
for human security(Lancet－5.16)
Gene patents
and the public good(Nature－5.15)
SARS-Associated
Coronavirus(NEJM－5.15)
Managing
SARS amidst Uncertainty(NEJM－5.15)
SARS and
Carlo Urbani(NEJM－5.15)
SARS, the
Internet, and the Journal(NEJM－5.15)
Coexisting
with viruses(CURRENT SCIENCE－5.10)
Comparative
analysis of the SARS coronavirus genome: a good start to a long journey(Lancet－5.9)
SARS: Fear
of global pandemic(Mol Ther－5.7)
SARS:experience
at Prince of Wales Hospital, Hong Kong(Lancet－5.4)
SARS,lay epidemiology,
and fear(Lancet－5.4)
Will SARS hurt
the world’s poor?(Lancet－5.4)
Solid response
to SARS almost(Nature Medicine－5.3)
Lessons
from SARS(Science－5.2)
Lessons from
SARS(CMAJ－5.2)
SARS, lay
epidemiology, and fear(Lancet－5.2)
The war Against
An Unknownpathogen-Rising To The Sars Challenge(Can Commun
Dis Rep－5.1)
An appropriate
response to SARS(Lancet Infectious Diseases－5.1)
Infectious
History(Science－4.25)
The other
war(BMJ－4.25)
The race to
outpace severe acute respiratory syndrome (SARS)(CMAJ－4.24)
Containing a
new infection with new technology: a Web-based response to SARS(CMAJ－4.24)
SARS: the struggle
for containment(CMAJ－4.24)
Current research
on respiratory viral infections(Antiviral Research－4.23)
Emerging stronger
from the China crisis(Lancet－4.19)
Severe acute
respiratory syndrome revisited(BMJ－4.19)
Faster . .
. but Fast Enough? Responding to the Epidemic of Severe Acute Respiratory
Syndrome(Lancet－4.2)
Case Clusters
of the Severe Acute Respiratory Syndrome(NEJM－3.31)
Top |
